A new method to visualize and to spare the ureters during SBRT for oligo metastatic patients.

Constraints Delineation Stenosis Stereotactic body radiation therapy Ureters Urography CT scan

Journal

Technical innovations & patient support in radiation oncology
ISSN: 2405-6324
Titre abrégé: Tech Innov Patient Support Radiat Oncol
Pays: England
ID NLM: 101762366

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 18 03 2021
revised: 21 05 2021
accepted: 30 05 2021
entrez: 30 6 2021
pubmed: 1 7 2021
medline: 1 7 2021
Statut: epublish

Résumé

This article describes a ureter-sparing procedure used to treat lymph node metastases with SBRT. We delivered 35 Gy in 5 fractions of 7 Gy to patients with lesions located less than 7 mm from the ureters using a urography CT scan for planification. Two dosimetry plans were created, one using a CT scan urography-based contour and the other using the native phase. PTV coverage were not statistically different but this technique was able to significantly reduce median delivered Dmax to the ureters. These preliminary results demonstrate the feasibility of locating the ureters in a planning CT scan to protect them.

Identifiants

pubmed: 34189285
doi: 10.1016/j.tipsro.2021.05.003
pii: S2405-6324(21)00023-8
pmc: PMC8215296
doi:

Types de publication

Journal Article

Langues

eng

Pagination

7-10

Informations de copyright

© 2021 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Radiographics. 2015 May-Jun;35(3):709-26
pubmed: 25815907
Int J Radiat Oncol Biol Phys. 1991 Mar;20(3):439-46
pubmed: 1995529
Radiographics. 1997 Nov-Dec;17(6):1455-73
pubmed: 9397458
Int J Radiat Oncol Biol Phys. 1988 May;14(5):939-46
pubmed: 3129384
Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):1093-104
pubmed: 12829147
Int J Radiat Oncol Biol Phys. 1981 Aug;7(8):999-1004
pubmed: 6795161
Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):320-334
pubmed: 30267761
Onkologie. 2003 Aug;26(4):334-40
pubmed: 12972698
Cancer. 1995 Feb 1;75(3):836-43
pubmed: 7828135

Auteurs

Emilien Muggeo-Bertin (E)

Radiation Oncology Service, Department of Oncology, Lausanne University Hospital, Lausanne, Vaud, Switzerland.

Raphael Moeckli (R)

Institute of Radiation Physics, Lausanne University Hospital, Lausanne, Vaud, Switzerland.

Veronique Vallet (V)

Institute of Radiation Physics, Lausanne University Hospital, Lausanne, Vaud, Switzerland.

Dominik Berthold (D)

Medical Oncology Service, Department of Oncology, Lausanne University Hospital, Lausanne, Vaud, Switzerland.

Sarah Godin (S)

Radiation Oncology Service, Department of Oncology, Lausanne University Hospital, Lausanne, Vaud, Switzerland.

Jean Bourhis (J)

Radiation Oncology Service, Department of Oncology, Lausanne University Hospital, Lausanne, Vaud, Switzerland.

Fernanda G Herrera (FG)

Radiation Oncology Service, Department of Oncology, Lausanne University Hospital, Lausanne, Vaud, Switzerland.
Immuno-oncology Service, Department of Oncology, Lausanne University Hospital, Lausanne, Vaud, Switzerland.
Ludwig Institute for Cancer Research, Lausanne Branch at University of Lausanne, Lausanne, Vaud, Switzerland.

Classifications MeSH